4//SEC Filing
ANADYS PHARMACEUTICALS INC 4
Accession 0001209191-08-045743
CIK 0001128495operating
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 1:16 PM ET
Size
6.2 KB
Accession
0001209191-08-045743
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2008-08-05+50,000→ 50,000 totalExercise: $2.74From: 2009-08-05Exp: 2018-08-04→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Granted in connection with Dr. Freddo's expansion of responsibility from Chief Medical Officer to Sr. Vice President, Drug Development and Chief Medical Officer.
- [F2]25% of the shares subject to the option shall vest and become exercisable one year from the date of the grant with the remaining shares subject to the option vesting in equal monthly installments evenly over the next three year period such that all shares subject to the option will be fully vested and exercisable as of August 5, 2012.
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeoperating
Related Parties
1- filerCIK 0001128495
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 1:16 PM ET
- Size
- 6.2 KB